Interview: Christopher Tsai, Chairman, Bionet, Taiwan
The chairman of Bionet reflects on past market challenges and the growing strength of Bionet’s reach both domestically and globally, and why Taiwan is the perfect size for a biotech…
Address: 2 Yuh-Der Road,Taichung City,Taiwan
Tel: +886 4 2205 2121
Web: http://www.cmuh.cmu.edu.tw/
As the hospital pertaining to the China Medical University, CMUH is committed to provide excellent medical services, clinical education and research, and the modernization of Chinese Medicine. It is also our mission to make continual improvement of clinical education, research and medical services and to launch strategic alliance with reputed medical institutions sharing the same belief of CMUH, in order to construct the China Medicine System for offering patient-focus, high-quality and excellent services.
CMUH’s seven goals include: (1) enhancement of total medical service quality; (2) development of holistic education in medicine and cultivation of medical talents; (3) localization and optimization of research environment by combining the CMU resources; (4) continual improvement of employee benefits and creation of quality work environment; (5) realization of the belief in ‘using what is taken from the society in the interest of the society’ and promotion of community preventive medicine, epidemic prevention, healthy city public health policies; (6) development of long-term care and geriatrics in response to the aging society and drawing up long-term care development strategy to enhance the quality of care for aging people; (7) Cross-Industry Cooperation to develop Biotechnology industrial park to devote medical research development related to human health and welfare.
The chairman of Bionet reflects on past market challenges and the growing strength of Bionet’s reach both domestically and globally, and why Taiwan is the perfect size for a biotech…
Taiwan’s current health minister reflects on Taiwan’s prestigious healthcare system, the problems in the first generation health insurance system that were fixed in the second, and strategies to rectify the…
Jaw-Jou Kang, former Director General of Taiwan Food & Drug Administration (TFDA) discusses the key successes the company has had since 2010, where it is looking to in the future…
The Deputy Executive Secretary of Taiwan’s National Development Fund discusses the recent shift in focus from semiconductors to biotech investments; why this has been a huge success thus far and…
The Vice President of Merits Health Products discusses the company’s main opportunities and challenges of the past 25 years, which countries are among its top buyers and its future plans…
YFY Biotech Management Company has not always been involved in the biotech sector. How has it evolved over the years? Yuen Foong Yu Group originally began as a paper mill…
Dr. Chen, you joined US-based Anchen Pharmaceuticals in 2009 to help the company form a spin-off in Taiwan. Why did a US-based company look to establish itself in Taiwan, and…
Over the past decade since its founding, what are some of the highlights in the transformation of Taiwan Advance Bio-Pharmaceutical Inc. (TABP) into a well established company? TABP was founded…
Mr. Lin, you enjoyed a decades-long career in the ICT industry before making the transition to healthcare. What can you tell our readers about the evolution of General Biologics Corp.…
Formosa Laboratories is one of Taiwan’s international pioneers in small molecules, entering the global arena at a very early stage. How did that decision come about? Generally speaking, Taiwan’s API…
PAREXEL has been in Asia Pacific (APAC) since the company entered Japan in 1995. It chose Taiwan as its regional base of operations with the 2007 acquisition of APEX, a…
The managing director of Burrill & Company discusses the biotech industry in Taiwan, the various hurdles the market faces and why there is so much potential for industry growth in…
See our Cookie Privacy Policy Here
